Table 2

Baseline characteristics of participants in respective trials. (N/a- data not available).

Author

Age mean (SD and/or range) years

Female:male (% female)

Mean BMI (SD)


Treatment group

Control group

Treatment group

Control group

Treatment group

Control group


Abt et al [21]

56.5

57.4

11:6 (64.7)

9:6 (60)

30.1

28.5

Buch et al [27]

50.4 (10.3, 26–69)

53.0 (9.7, 31–72)

61:14 (81.3)

46:26 (63.9)

28.9

28.5

Buchbinder et al [10]

52.2 (12.8)

54.2 (12.0)

46:3 (57.5)

47:3 (58.0)

29.5

28.9

Cosentino et al [33]

55.6 (45–68)

18:12 (60.0)

25:5 (83.3)

N/a

N/a

Haake et al [11]

53.1 (10.8)

52.9 (10.8)

98:37 (72.6)

106:30 (77.9)

29.4 (4.9)

29.7 (4.8)

Krischek et al [22]

54.0

55.0

(56.0)

(72.0)

N/a

N/a

Ogden et al [28]

49.6 (20–79)

171 (65.9)

N/a

N/a

Rompe et al [32]

44.0 (26–61)

49.0 (31–63)

21:29 (42.0)

20:30 (40.)

N/a

N/a

Rompe et al [30]

47.0 (26–61)

51.0 (31–58)

5:10 (33.3)

6:9 (40)

N/a

N/a

Rompe et al [31]

43.0 (32–59)

40.0 (30–61)

10:12 (45.5)

13:10 (56.5)

N/a

N/a

Speed et al [12]

51.7 (25–76)

52.5 (30–73)

26:20 (56.5)

25:17 (59.5)

N/a

N/a


Thomson et al. BMC Musculoskeletal Disorders 2005 6:19   doi:10.1186/1471-2474-6-19

Open Data